The impact of metabolic syndrome on survival outcomes in urothelial carcinoma: a retrospective cohort study - Top-Institutions - MDSpire

The impact of metabolic syndrome on survival outcomes in urothelial carcinoma: a retrospective cohort study

  • By

  • Aspasia Manta

  • Afroditi Roumpou

  • Maria Gerogianni

  • Roubini Zakopoulou

  • Kimon Tzannis

  • Areti Mamali

  • Vasiliki Malamatini

  • Konstantina Kakogianni

  • Aristotelis Bamias

  • Melpomeni Peppa

  • June 30, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Attikon University Hospital
    Attikon University Hospital

    Athens, Greece

    Key Differentiators

    • Urology

  • #2

    Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
    Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation

    Hualien, Taiwan

    Key Differentiators

    • Urology

  • #3

    Clinical Research Office of the Endourology Society (CROES)
    Clinical Research Office of the Endourology Society (CROES)

    International, N/A

    Key Differentiators

    • Urology

Original Source(s)

The impact of metabolic syndrome on survival outcomes in urothelial carcinoma: a retrospective cohort study

  • by Aspasia Manta, Afroditi Roumpou, Maria Gerogianni, Roubini Zakopoulou, Kimon Tzannis, Areti Mamali, Vasiliki Malamatini, Konstantina Kakogianni, Aristotelis Bamias, Melpomeni Peppa

  • June 30, 2026

Related Content

This Week's CGT News: World's First Solid Tumor CAR T Approved in China 

  • June 30, 2026

  • 6 min
Nivolumab in previously treated metastatic renal cell carcinoma: real-world data from the Czech Republic and Slovakia

Long term survival of patients with alpha-fetoprotein-positive hepatoid adenocarcinoma of the gallbladder: a case report and literature review